ApolloLIMS provides enterprise-level LIMS software, offering a comprehensive, configurable platform to streamline lab operations. The company serves a wide range of laboratory end markets, including toxicology, molecular, public health and full-service reference labs utilized by providers.

Family Ties provides behavioral health services to at-risk youth and families, focusing on skill-building and independent navigation.

Lieberman Research conducts primary market research and analytics for pharmaceutical and healthcare clients using physician and patient engagement.

Lead Capital Partners sold Common Cents Systems, Inc. (ApolloLIMS) to CliniSys Group, a subsidiary of Roper Technologies.

Lead Capital Partners sold The Hardenbergh Group to BV Investment Partners in 2023.

Lead Capital Partners made a platform investment in Viva Day Spa in partnership with its founders and management team.

Lead Capital Partners-backed Signet Leadership acquired Elsner Family Dentistry, a dental practice in Westfield, Indiana.

Lead Capital Partners hired Mr. Swenson in 2024 to focus on investment origination, due diligence, and portfolio management.

Lead Capital Partners hired Mr. Grote in 2022 to focus on portfolio management, investment origination, and transaction execution.

Lead Capital Partners hired Mr. Royal in 2024 to focus on investment origination, due diligence, and portfolio management.

Lead Capital Partners is an investment firm founded in 2011 to acquire majority interests in privately-owned healthcare companies.

Lead Capital Partners is a private equity firm focused exclusively on healthcare companies in the lower middle market.

Lead Capital Partners collaborates closely with management teams to support operational and strategic growth across companies at every stage.

Lead represents high-net-worth families who acquire majority ownership interests in lower middle market healthcare companies.

3817 Bedford Avenue, Suite 220, Nashville, TN 37215

At Lead Capital, families, entrepreneurs and investors partner to accelerate growth in healthcare companies for the long term.